Aerovate Therapeutics (AVTE) Earnings Date & Reports
A.I. Advisor
published Earnings
AVTE is expected to report earnings to rise 3.18% to -85 cents per share on August 26
Q2'24
Est.
$-0.86
Q1'24
Missed
by $0.07
Q4'23
Missed
by $0.06
Q3'23
Missed
by $0.02
Q2'23
Missed
by $0.06
The last earnings report on May 13 showed earnings per share of -82 cents, missing the estimate of -75 cents. With 133.51K shares outstanding, the current market capitalization sits at 59.47M.